Tüysüz, B.; Bozlak, S.; Uludağ Alkaya, D.; Ocak, S.; Kasap, B.; Sunamak Çifçi, E.; Seker, A.; Bayhan, I.A.; Apak, H.
Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients. Cancers 2023, 15, 1872.
https://doi.org/10.3390/cancers15061872
AMA Style
Tüysüz B, Bozlak S, Uludağ Alkaya D, Ocak S, Kasap B, Sunamak Çifçi E, Seker A, Bayhan IA, Apak H.
Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients. Cancers. 2023; 15(6):1872.
https://doi.org/10.3390/cancers15061872
Chicago/Turabian Style
Tüysüz, Beyhan, Serdar Bozlak, Dilek Uludağ Alkaya, Süheyla Ocak, Büşra Kasap, Evrim Sunamak Çifçi, Ali Seker, Ilhan Avni Bayhan, and Hilmi Apak.
2023. "Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients" Cancers 15, no. 6: 1872.
https://doi.org/10.3390/cancers15061872
APA Style
Tüysüz, B., Bozlak, S., Uludağ Alkaya, D., Ocak, S., Kasap, B., Sunamak Çifçi, E., Seker, A., Bayhan, I. A., & Apak, H.
(2023). Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients. Cancers, 15(6), 1872.
https://doi.org/10.3390/cancers15061872